The FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.

Source: Reason.com · Bias: Center Right

Summary

A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost.

Related Coverage

More Headlines From February 19, 2026

The FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.
Reason.com

The FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.

Center Right

A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost.